Logo image of OFIX

ORTHOFIX MEDICAL INC (OFIX) Stock Fundamental Analysis

NASDAQ:OFIX - Nasdaq - US68752M1080 - Common Stock - Currency: USD

10.67  +0.04 (+0.38%)

After market: 10.67 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OFIX. OFIX was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of OFIX have multiple concerns. While showing a medium growth rate, OFIX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OFIX had positive earnings in the past year.
OFIX had a positive operating cash flow in the past year.
In the past 5 years OFIX reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: OFIX reported negative operating cash flow in multiple years.
OFIX Yearly Net Income VS EBIT VS OCF VS FCFOFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of OFIX (-17.38%) is comparable to the rest of the industry.
OFIX has a Return On Equity of -31.22%. This is comparable to the rest of the industry: OFIX outperforms 54.55% of its industry peers.
Industry RankSector Rank
ROA -17.38%
ROE -31.22%
ROIC N/A
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
OFIX Yearly ROA, ROE, ROICOFIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

OFIX's Gross Margin of 67.15% is fine compared to the rest of the industry. OFIX outperforms 72.73% of its industry peers.
In the last couple of years the Gross Margin of OFIX has declined.
OFIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
OFIX Yearly Profit, Operating, Gross MarginsOFIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OFIX has been increased compared to 1 year ago.
Compared to 5 years ago, OFIX has more shares outstanding
OFIX has a worse debt/assets ratio than last year.
OFIX Yearly Shares OutstandingOFIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OFIX Yearly Total Debt VS Total AssetsOFIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

OFIX has an Altman-Z score of 1.06. This is a bad value and indicates that OFIX is not financially healthy and even has some risk of bankruptcy.
OFIX has a Altman-Z score (1.06) which is in line with its industry peers.
OFIX has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.38, OFIX is in line with its industry, outperforming 45.99% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACCN/A
WACC7.76%
OFIX Yearly LT Debt VS Equity VS FCFOFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

OFIX has a Current Ratio of 2.71. This indicates that OFIX is financially healthy and has no problem in meeting its short term obligations.
OFIX has a Current ratio (2.71) which is comparable to the rest of the industry.
OFIX has a Quick Ratio of 1.50. This is a normal value and indicates that OFIX is financially healthy and should not expect problems in meeting its short term obligations.
OFIX's Quick ratio of 1.50 is in line compared to the rest of the industry. OFIX outperforms 42.25% of its industry peers.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 1.5
OFIX Yearly Current Assets VS Current LiabilitesOFIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 400.00% over the past year.
Measured over the past years, OFIX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -63.14% on average per year.
Looking at the last year, OFIX shows a small growth in Revenue. The Revenue has grown by 5.86% in the last year.
The Revenue has been growing by 11.69% on average over the past years. This is quite good.
EPS 1Y (TTM)400%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%38.46%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%2.67%

3.2 Future

Based on estimates for the next years, OFIX will show a very negative growth in Earnings Per Share. The EPS will decrease by -356.00% on average per year.
The Revenue is expected to grow by 4.93% on average over the next years.
EPS Next Y-24427%
EPS Next 2Y-1104.39%
EPS Next 3Y-356%
EPS Next 5YN/A
Revenue Next Year2.05%
Revenue Next 2Y3.58%
Revenue Next 3Y4.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OFIX Yearly Revenue VS EstimatesOFIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
OFIX Yearly EPS VS EstimatesOFIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 177.83, OFIX can be considered very expensive at the moment.
OFIX's Price/Earnings ratio is a bit cheaper when compared to the industry. OFIX is cheaper than 63.64% of the companies in the same industry.
OFIX is valuated expensively when we compare the Price/Earnings ratio to 27.46, which is the current average of the S&P500 Index.
OFIX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 177.83
Fwd PE N/A
OFIX Price Earnings VS Forward Price EarningsOFIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OFIX Per share dataOFIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as OFIX's earnings are expected to decrease with -356.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1104.39%
EPS Next 3Y-356%

More info and screens

0

5. Dividend

5.1 Amount

OFIX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORTHOFIX MEDICAL INC

NASDAQ:OFIX (7/21/2025, 8:00:02 PM)

After market: 10.67 0 (0%)

10.67

+0.04 (+0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-05 2025-08-05/amc
Inst Owners88.16%
Inst Owner Change0.15%
Ins Owners1.33%
Ins Owner Change10.08%
Market Cap418.05M
Analysts83.64
Price Target22.75 (113.21%)
Short Float %6.32%
Short Ratio5.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)109.71%
Min EPS beat(2)80.19%
Max EPS beat(2)139.22%
EPS beat(4)4
Avg EPS beat(4)122.63%
Min EPS beat(4)80.19%
Max EPS beat(4)145.75%
EPS beat(8)8
Avg EPS beat(8)114.38%
EPS beat(12)11
Avg EPS beat(12)88.65%
EPS beat(16)13
Avg EPS beat(16)70.45%
Revenue beat(2)0
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-0.65%
Max Revenue beat(2)-0.61%
Revenue beat(4)0
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.26%
Revenue beat(8)2
Avg Revenue beat(8)-0.82%
Revenue beat(12)3
Avg Revenue beat(12)-2.09%
Revenue beat(16)4
Avg Revenue beat(16)-1.23%
PT rev (1m)-8.61%
PT rev (3m)-8.23%
EPS NQ rev (1m)-4800%
EPS NQ rev (3m)-4800%
EPS NY rev (1m)-1545.45%
EPS NY rev (3m)-1763.99%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-3.59%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-1.12%
Valuation
Industry RankSector Rank
PE 177.83
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF 16.08
P/B 0.91
P/tB 2.3
EV/EBITDA N/A
EPS(TTM)0.06
EY0.56%
EPS(NY)-1.43
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.66
OCFY6.22%
SpS20.53
BVpS11.7
TBVpS4.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.38%
ROE -31.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.15%
FCFM N/A
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
F-Score5
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.67%
Cap/Sales 3.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.71
Quick Ratio 1.5
Altman-Z 1.06
F-Score5
WACC7.76%
ROIC/WACCN/A
Cap/Depr(3y)86.5%
Cap/Depr(5y)81.89%
Cap/Sales(3y)6%
Cap/Sales(5y)5.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%38.46%
EPS Next Y-24427%
EPS Next 2Y-1104.39%
EPS Next 3Y-356%
EPS Next 5YN/A
Revenue 1Y (TTM)5.86%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%2.67%
Revenue Next Year2.05%
Revenue Next 2Y3.58%
Revenue Next 3Y4.93%
Revenue Next 5YN/A
EBIT growth 1Y4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.12%
EBIT Next 3Y53.95%
EBIT Next 5YN/A
FCF growth 1Y92.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y168.77%
OCF growth 3Y11.71%
OCF growth 5Y-4.22%